Abstract
There is limited prospective real-world data describing the long-term changes in clinical outcomes and disease burden for individual advanced PD patients. The understanding of the treatment patterns and their differential impact over time is also limited. We describe the changing clinical outcomes and disease burden of advancing Parkinson's disease in patients with motor fluctuations no longer controlled by current PD medications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
